Exchange Bank Sells 73 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Exchange Bank lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 8.7% during the 1st quarter, HoldingsChannel.com reports. The fund owned 764 shares of the healthcare conglomerate’s stock after selling 73 shares during the period. Exchange Bank’s holdings in UnitedHealth Group were worth $400,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of UNH. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group during the 4th quarter worth $26,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth $30,000. Finally, Promus Capital LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth $32,000. Institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, CFO John F. Rex acquired 17,175 shares of the stock in a transaction on Friday, May 16th. The shares were bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the purchase, the chief financial officer now owns 203,796 shares of the company’s stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now directly owns 6,033 shares of the company’s stock, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock valued at $31,607,768 over the last ninety days. Insiders own 0.28% of the company’s stock.

UnitedHealth Group Stock Up 2.3%

Shares of UNH opened at $310.70 on Thursday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The stock’s 50 day moving average is $395.60 and its two-hundred day moving average is $478.20. The firm has a market cap of $281.85 billion, a P/E ratio of 20.05, a PEG ratio of 1.37 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the business posted $6.91 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be paid a $2.21 dividend. The ex-dividend date is Monday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.85%. UnitedHealth Group’s payout ratio is currently 37.02%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Piper Sandler decreased their price objective on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research note on Tuesday, June 3rd. Truist Financial restated a “buy” rating and set a $360.00 price objective (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Bank of America cut UnitedHealth Group from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. Hsbc Global Res cut UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. Finally, Wolfe Research decreased their price target on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research note on Tuesday, May 20th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $426.52.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.